Ai-Genetika Inc.: federal grants and contributions: 14 agreements; $2.2M value; 3 departments; 5 programs.
Assay record ASY-CA-083VXE10NI · Cite as: Assay Systems, “Ai-Genetika Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/ai-genetika-inc/
Business start-up : The project aims to increase the analytical capacity of biotechnology company which specializes in the early detection of diseases as well as the prediction and simulation of various health conditions.
Development of human metabolomic profiling methods using a combination of high-performance tools (mass spectrometry + machine learning) and genetic editing (CRISPR-Cas).
Creation of virtual human twins using patients' metabolomic profiles and artificial intelligence to detect and predict early cancer development and help healthcare professionals.
Acquisition of equipment: The project aims to increase the analytical capacity of a biotechnology company specialized in the early detection, prediction and simulation of various health conditions.
Development of a diagnostic tool for different types and stages of cancers.
Development of a standard operating procedure to generate robust CRISPR-Cas assay data. This data will be used to train machine learning algorithms for the detection and prediction of on/off target effects in CRISPR-Cas assays.
Development of models and algorithms in machine learning.
Development of artificial intelligence tools to link different biomarkers to the health status of individuals.
Development of artificial intelligence tools to link different biomarkers to the health status of individuals.
Business development support
Characterization and implementation of new systems for targeted genome editing by CRISPR-Cas9 systems.
The project will fund the development of the firm's intellectual property capacity
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
All grants from Canada Economic Development for Quebec Regions
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.